WOK — Work Medical Technology Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for Work Medical Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 52.5 | 45.9 | 19.7 | 13.6 |
Cost of Revenue | ||||
Gross Profit | 10.8 | 8.64 | 4.42 | 4.14 |
Selling / General / Administrative Expenses | ||||
Research And Development | ||||
Unusual Expense / Income | ||||
Total Operating Expenses | 51.1 | 41.9 | 19.1 | 13.2 |
Operating Profit | 1.4 | 3.97 | 0.638 | 0.412 |
Total Net Non Operating Interest Income / Expense | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 1.33 | 7.34 | 1.11 | 0.11 |
Provision for Income Taxes | ||||
Net Income After Taxes | 1.22 | 6.27 | 0.944 | 0.063 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | 1.16 | 5.96 | 0.865 | 0.112 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 1.16 | 5.96 | 0.865 | 0.112 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 0.364 | 0.411 | 0.149 | 0.008 |
Dividends per Share |